Drug Cuts Treatment Modifications From Chemotherapy-Induced Thrombocytopenia

(MedPage Today) — The use of romiplostim (Nplate) reduced treatment modifications due to chemotherapy-induced thrombocytopenia (CIT) in patients with gastrointestinal cancers, a phase III randomized trial showed.
Among 165 patients, 84% of those…